Kiora PharmaceuticalsKPRX
13F holders, Q3 2024 (September 30)18holders +3
5new positions
2sold out
1famous investor
$3.66avg. 13F price*
At the end of Q3 2024, 18 institutions reported holding Kiora Pharmaceuticals Inc. (KPRX) in their 13F filings, up 3 from Q2 2024. 5 opened new positions and 2 sold out. The largest holders were AIGH Capital Management LLC ($935K), Nantahala Capital Management, LLC ($773K) and Stonepine Capital Management, LLC ($741K). One famous investor held it Ken Griffin (0.0% of Citadel Advisors's portfolio).
- Company
- Kiora Pharmaceuticals Inc.
- CUSIP
- 49721T507
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q2 2024 → Q3 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 5 | $845K |
| Exits | 2 | $8 |
All 13F filers, Q2 2024 → Q3 2024: 255,519 shares bought and 7,994 shares sold, net +247,525 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 18 holders
| AIGH Capital Management LLC | 0.44% | Reduce 0.0% | 255,555 | $935K |
| Nantahala Capital Management, LLC | 0.07% | No change | 211,110 | $773K |
| Stonepine Capital Management, LLC | 0.47% | New | 202,400 | $741K |
| ADAR1 Capital Management, LLC | 0.12% | Add +13.9% | 196,551 | $719K |
| Alyeska Investment Group, L.P. | 0.00% | No change | 180,780 | $662K |
| Velan Capital Investment Management LP | 0.49% | No change | 122,223 | $447K |
| Geode Capital Management, LLC | 0.00% | Add +5.2% | 14,483 | $53K |
| Susquehanna International Group, LLP | 0.00% | New | 11,382 | $42K |
| Citadel Advisors | 0.00% | New | 10,114 | $37K |
| Sabby Management, LLC | 0.25% | New | 5,000 | $18K |
| Tower Research Capital LLC (TRC) | 0.00% | New | 1,954 | $7K |
| BlackRock, Inc. | 0.00% | — | 1,606 | $6K |
| UBS Group AG | 0.00% | Reduce -95.8% | 354 | $1K |
| NewEdge Advisors, LLC | 0.00% | No change | 22 | $81 |
| Bank of America Corp. | 0.00% | Add +10.0% | 22 | $80 |
| US Bancorp \de | 0.00% | No change | 8 | $29 |
| Osaic Holdings, Inc. | 0.00% | Reduce -86.4% | 3 | $10 |
| Activest Wealth Management | 0.00% | Reduce -33.3% | 2 | $7 |
"% of holder's portfolio" is KPRX's weight in each manager's 13F, not the share of Kiora Pharmaceuticals Inc. the manager owns.